One under-the-radar biotech company could be your next big bet in the IPO market, says Renaissance Capital co-founder

Under-the-radar biotechnology company PPD could be worth watching as it gears up for a 2020 initial public offering, says Kathleen Smith, co-founder and chairman at Renaissance Capital.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.